Evidence map›Paper›PMID 37460772›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2023

CB1R blockade unmasks TRPV1-mediated contextual fear generalization in female, but not male rats.

Kylie A Huckleberry, Roberto Calitri, Anna J Li, Mackenna Mejdell, Ashna Singh, Vasvi Bhutani, Mikaela A Laine, Andrei S Nastase, Maria Morena, Matthew N Hill and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Dissociable control of depression and visceral pain by the pICNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  4. Review
  5. Article
  6. Endocannabinoids inhibit contextual fear memory generalization via hippocampal GABAergic synaptic transmission.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Merkel cell stimulation in fear and sensory signaling.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  8. Sex Differences in Neural Circuits Underlying Fear Processing.Current topics in behavioral neurosciences · 2025
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Kylie A HuckleberryDepartment of Psychology, Northeastern University, Boston, MA, USA.
Roberto CalitriDepartment of Psychology, Northeastern University, Boston, MA, USA.
Anna J LiDepartment of Psychology, Northeastern University, Boston, MA, USA.
Mackenna MejdellDepartment of Psychology, Northeastern University, Boston, MA, USA.
Ashna SinghDepartment of Psychology, Northeastern University, Boston, MA, USA.
Vasvi BhutaniDepartment of Psychology, Northeastern University, Boston, MA, USA.
Mikaela A LaineDepartment of Psychology, Northeastern University, Boston, MA, USA.ORCID 0000-0003-2989-2527
Andrei S NastaseHotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Maria MorenaHotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.ORCID 0000-0001-6590-8130
Matthew N HillHotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Rebecca M ShanskyDepartment of Psychology, Northeastern University, Boston, MA, USA. r.shansky@northeastern.edu.
Northeastern University · USUniversity of Calgary · CA

Funding

TRPV1 signaling as a sex-specific mechanism of contextual fear generalizationR21MH122914 · NIMH · NORTHEASTERN UNIVERSITY · PI SHANSKY, REBECCA M · 2020 to 2021
$432k
NIMH NIH HHS R21 MH122914NIMH NIH HHS R21 MH122914-01
6 · The paper itself

Abstract

Increasing evidence suggests that the neurobiological processes that govern learning and memory can be different in males and females, but many of the specific mechanisms underlying these sex differences have not been fully defined. Here we investigated potential sex differences in endocannabinoid (eCB) modulation of Pavlovian fear conditioning and extinction, examining multiple defensive behaviors, including shock responsivity, conditioned freezing, and conditioned darting. We found that while systemic administration of drugs acting on eCB receptors did not influence the occurrence of darting, females that were classified as Darters responded differently to the drug administration than those classified as Non-darters. Most notably, CB1R antagonist AM251 produced an increase in cue-elicited freezing and context generalization selectively in female Non-darters that persisted across extinction and extinction retrieval tests but was prevented by co-administration of TRPV1R antagonist Capsazepine. To identify a potential synaptic mechanism for these sex differences, we next employed biochemical and neuroanatomical tracing techniques to quantify anandamide (AEA), TRPV1R, and perisomatic CB1R expression, focusing on the ventral hippocampus (vHip) given its known role in mediating contextual fear generalization. These assays identified sex-specific effects of both fear conditioning-elicited AEA release and vHip-BLA circuit structure. Together, our data support a model in which sexual dimorphism in vHip-BLA circuitry promotes a female-specific dependence on CB1Rs for context processing that is sensitive to TRPV1-mediated disruption when CB1Rs are blocked.

Indexed as

FearLearningAnimalsConditioning, ClassicalFemaleHippocampusMaleRats

Identifiers

PMID37460772
PMCPMC10425366
OpenAlexW4384498976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.